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ABSTRACT  
Background: Estimation of Quality of life is a useful outcome measure to know about epilepsy care from patient’s perspective. Assessing QOL 
of epileptic patients is important so as to manage the epilepsy and to implement some interventional programs in order to improve the quality 
of life of these patients. The study aims to find out the impact of epilepsy on quality of life of epileptic patients  
Material and method: This was a cross-sectional, questionnaire-based study, conducted from March to August 2019 for a period of 6 months, 
after approval from Institutional Ethics Committee. Data was analyzed using Statistical Package for Social Sciences (SPSS) version 25. The 
quality of life in epilepsy (QOLIE-31) was used for collecting data on health-related QOL. 
Result: The study group consisted of 65 patients of whom 48 were males (73.84%) and 17 were females (26.15%). Their ages ranged from 19 
to 60 years. (mean age: 35.65). Majority of the patients were in the age range of 30-41 (40%). 50.8% participants were from nuclear family and 
49.2% were from joint family system. Most of the patients had lower class socioeconomic status (61.5%). As regard to the employment status, 
38.4% of patients were full time employed, 13.8% were part time employed. 29.2% were unemployed and 9.23% were retired and 9.23% were 
students.  The medication analysis revealed that 30.6% of the participants were on monotherapy whereas 69.0% were on polytherapy. The 
mean total QOLIE-31 score was 39.12 (SD-5.00).  
Conclusion: Epileptic patients had poor QOL with low total QOLIE-31 score, unemployment, use of combination therapy and people belonging 
to lower class were associated with lower quality of life in individuals with epilepsy.  
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INTRODUCTION 
EPILEPSY 
A paroxysmal event which arises due to excessive discharge 
from hyper synchronous neurons is known as seizure. 
Epilepsy is a central nervous system disorder in which a 
person experience recurrent epileptic seizures. There is 
disruption of electrical activity in the brain which causes 
synchronized and excessive neuronal discharge.(1) Epilepsy 
is not a communicable disease. The most common type of 
epilepsy, affecting 6 out of 10 people with the disorder, is 
known as idiopathic epilepsy the cause of which is unknown. 
On the other hand secondary epilepsy or symptomatic 
epilepsy is the epilepsy with an identifiable cause. 
Approximately 50 million people worldwide suffer from 
epilepsy, which makes it one of the most prevalent 
neurological disease. Globally, each year around 2.4 million 
people are diagnosed with epilepsy. An estimated 80% of the 
people suffering from epilepsy are found in low and middle 
income countries. Approximately 70% of the time, people 
with epilepsy responds to the treatment being given. About 
three fourth of people living in low and middle income 
countries that suffers from epilepsy do not get the treatment 
they require.(2) Neurodevelopment delay, cognitive 
impairment, comorbid depression and anxiety are usually 
seen in epileptic patients.(3) Moreover, epileptic patients face 
educational and vocational challenges, have problems with 
independent living, and become victims of stigma and 
common public misunderstanding.(4)  Comorbid and 
psychosocial issues like this must be taken into account 
when treating and caring for epileptic patients. The 
International League Against Epilepsy (ILEA) defines 
epilepsy not only as “a chronic condition of the brain 
characterized by an enduring propensity to generate 
epileptic seizures” but also by “the cognitive, psychological, 
neurobiological and social consequences of this condition.” 
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(5) These common issues and comorbidities must be 
addressed by the clinicians treating the epilepsy. Treatment 
should not only be given to reduce the frequency of seizures, 
but should also aim at minimizing the side effects, taking 
into account the coexisting health and social problems faced 
by the patient and thereby improving the quality of life 
(QOL). 
The prerequisite of this study is to determine the burden of 
disease, injuries and disabilities and to measure Health 
Related Quality of Life (HRQOL) which will help to monitor 
progress so as to attain the Nation’s health goal and 
assessment of HRQOL surveillance data can identify 
individuals with relatively poor perceived health and help to 
guide interventions in order to improve their situations and 
avoid more serious consequences. 
Estimation of Quality of life is a useful outcome measure to 
know about epilepsy care from patient’s perspective. 
Assessing QOL of epileptic patients is important so as to 
manage the epilepsy and to implement some interventional 
programs in order to improve the quality of life of these 
patients.  
MATERIAL AND METHODS 
The study was conducted in Tertiary Care Hospital, 
Dehradun. The patients attending the outpatient and 
inpatient facilities of the department of neurology and 
general medicine with clinical diagnosis of epilepsy were 
included in the study. This was a cross-sectional, 
questionnaire-based study, conducted from March to August 
2019 for a period of 6 months,  Total 65 epileptic patients 
were enrolled in the study that satisfies the inclusion and 
exclusion criteria. Inclusion criteria were male and female 
patients who were willing to participate of age above 18 
years, and with the diagnosis of epilepsy for at least one 
year. Exclusion criteria were patients with other 
concomitant chronic illness and psychiatric disorder, 
patients in unconscious state and patient below 18 years and 
not willing to participate.  
They were explained the nature and purpose of the study 
and necessary consent were obtained. Questionnaires were 
developed to collect socio-demographic data (age, gender, 
employment status, qualification etc.) and clinical 
characteristics of epilepsy (age at onset, seizure frequency 
and medication etc.) 
The quality of life in epilepsy (QOLIE-31) was used for 
collecting data on health-related QOL with the permission of 
QOLIE development group. 
 It is a epilepsy specific questionnaire which includes 31 
questions containing seven domains to be measured: 1) 
Seizure worry; 2) Overall Quality of life; 3) Emotional well-
being; 4) Energy/fatigue; 5) Cognitive functioning; 6) 
Medication effects; 7) Social functioning. 
Statistical analysis 
Data was analyzed using Statistical Package for Social 
Sciences (SPSS) version 25. Paired sample t- test was used to 
compare the means between groups. Paired sample 
correlation which shows bivariate Pearson correlation 
coefficient was used to calculate the correlation. The results 
were tabulated and graphically represented using Microsoft 
Office for Windows 2010. 
RESULTS 
The study group consisted of 65 patients of whom 48 were 
males (73.84%) and 17 were females (26.15%). Their ages 
ranged from 19 to 60 years. (mean age: 35.65). Majority of 
the patients were in the age range of 30-41 (40%). 50.8% 
participants were from nuclear family and 49.2% were from 
joint family system. Most of the patients had lower class 
socioeconomic status (61.5%). 33.9% population was living 
in urban areas and 66.1% in urban areas. As regard to the 
employment status, 38.4% of patients were full time 
employed, 13.8% were part time employed. 29.2% were 
unemployed and 9.23% were retired and 9.23% were 
students.  The medication analysis revealed that 30.6% of 
the participants were on monotherapy whereas 69.0% were 
on polytherapy. 44.7% people were single, 47.6 % were 
married and 7.7% were widow.  
Age group of 21-30 had the highest percentage of onset age 
of epilepsy with 35.50%. And lowest percentage of 1.50% 
between the age range of 41-50. Generalized seizures were 
most common with the percentage of 72.30% and partial 
seizure had 18.50% prevalence. Other seizure types 
contributed 9.20%. 30.8% individuals never missed 
medication, 49.3% missed medicine less often than once a 
month, 16.9% missed medicine less often than once a week 
and 3% were drug defaulter. 7.69% people had seizure once 
or more in a week, 46.10% had seizure once or more in a 
month, 43% had seizure once or more in a year and 3.07% 
had seizure not at all in the past year. 
With p-value of <0.05 the type of therapy data, 
socioeconomic status and employment status showed a 
statistically significant difference between the means of the 
population. 
The mean total score of QOLIE-31 was 39.12. The highest 
mean score was the medication effects-32.24 and the lowest 
was overall quality of life-15.72.  
Total score of QOLIE-31 subscales 
The mean total score of QOLIE-31 was 39.12. The highest 
mean score was the medication effects-32.24 and the lowest 
was overall quality of life-15.72. 
Table 1- 
SUBSCALES OF QOLIE-31 MEAN (SD) 
Seizure worry (SW) 28.28 (0.68) 
Overall quality of life (OQ) 15.72 (0.83) 
Emotional well-being (EWB) 18.67 (1.53) 
Energy/fatigue (EF) 25.82 (0.92) 
Cognitive function (CF) 31.61 (2.01) 
Medication effect (ME) 32.24 (0.31) 
Social function (SF) 27.92 (0.96) 
Total Quality of life score (TQOL) 39.12 (5.00) 
  
 
Figure 1- Total score of QOLIE-31 subscales 
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Comparison of total QOLIE-31 score with respect to type 
of therapy 
Paired sample correlation showed statistical significance 
between type of therapy (p value < 0.05) and there exist 
positive correlation between the groups. 
Table 4.2- Total QOLIE-31 score according to type of 
therapy 
TYPE OF THERAPY MEAN (SD) 
Monotherapy 39.96 (3.19) 
Combination therapy 37.38 (5.30) 
 
 
Figure 4.2- Total QOLIE-31 score according to type of 
therapy 
Comparison of total QOLIE-31 score with respect to 
socioeconomic status 
Paired sample correlation show statistical significance 
between socioeconomic status (p value < 0.05). And a 
positive correlation exists between the groups. 
Table 3.1.6-Total QOLIE-31 score according to 
socioeconomic status 
SOCIOECONOMIC STATUS MEAN (SD) 
Lower class  38.95 (5.27) 
Middle class 39.39 (4.63) 
 
 
Figure 3.1.6-Total QOLIE-31 score according to 
socioeconomic status 
Comparison of total QOLIE-31 score with respect to 
employment status 
Paired sample correlation showed a negative correlation 
between students and unemployed group and there was 
statistical difference in means students and unemployed 
group (p value <0.05). And in other groups there was no 
statistical significance. 
Table 3.1.5-Total QOLIE-31 score according to 
employment status 
EMPLOYMENT STATUS MEAN (SD) 
Student  37.15 (2.36) 
Full time employment 41.80 (4.94) 
Part time employment 39.41 (4.14) 
Unemployed 36.75 (4.76) 
Retired  37.00 (4.56) 
 
 
Figure 3.1.5-Total QOLIE-31 score according to 
employment status 
DISCUSSION 
Epilepsy is not a communicable disease, but it has an 
enormous social stigma and people with epilepsy usually 
have lower quality of life as compare to other individuals. (6)  
The disorder is usually considered to be witchcraft or people 
think that the patients of this disorder are possessed by 
some spirits and believe that those with epilepsy are cursed 
and the society usually treats them as insane or psychiatric 
patient. (7)   It can affect people economically, socially and 
culturally. In India and China, epilepsy may be used as 
justification to deny marriage.[8]  The stigma may result in 
some people with epilepsy denying that they have ever had 
seizures.[9] The present study assesses the various aspects 
like socio-demographic and clinical characteristics that 
affects the health related quality of life in patients with 
epilepsy. 
The mean total score of QOLIE-31 of this study was 39.12  
(SD-5.00)  , which is low as compare to study conducted by 
Gebre AH et al (10)  mean total score of 77.97 (SD-20.78) 
In this study, medication effect had the highest mean score, 
32.24 (SD- 0.31). This indicates that patients have 
experienced low physical and mental effects related to anti-
epileptic drugs. In contrast, overall QOL functioning was 
with the lowest mean score, 15.7 (SD- 0.83), which indicates 
things in the past time were worse and difficult. The findings 
were similar with the study conducted by Norsa’adah B et 
al (11) who noticed that worrying about seizure had the 
major contribution on QOL, while medication effect had the 
least. 
The study conducted by Mishal Alosaimi A et al (12) shows 
that being female was associated with low seizure worry 
score which indicates that being female was a risk for worry 
and fear for seizure. Similar findings were recorded in this 
study also. Although Brusturen Bota E et al (13) concluded 
that gender did not affect quality of life. Ali Gholami et al 
(14) noted that female patients have better QOL. 
There is mixed opinion regarding the impact of marital 
status on the QOL. Prem Singh et al (15) concluded from his 
study that QOL falls with single status and married people 
have better QOL. This study shows that widowers have low 
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QOL as compared to single and married people and married 
people had better QOL when compared with single people. 
However, study conducted by Ashwin M et al (16) showed 
that being married was associated with poor QOL scores 
among people with seizure disorder. And according to 
Brusturen Bota E et al (13) marital status did not influence 
QOL of patients. 
There are many studies suggesting that patients on 
monotherapy have better QOL than the patients who are on 
polytherapy. (17,18, 19, 20, 21, 22, 23) Similar finding was found in 
our study also. Patients on polytherapy had more seizure 
worry and the energy/fatigue and cognitive function as well 
as social function score was low. The overall quality of life of 
patients on polytherapy was low. 
In this study, unemployment had a negative impact on QOL 
of patients; they had more seizure worried and were not 
social. Next were the retired patients who were having low 
QOL scores. The people from lower class and living in rural 
areas had low QOLIE scores as compare to middle class 
families and people living in urban areas. Similar findings 
were recorded by Mohamed Shakir et al (24), Paramadam 
Srujana M et al (19) and Brusturen-Bota E et al (13) 
In this study, the patients who were complaint with the 
medications had good QOL; except the patients who were 
drug defaulters, although they were less in number but they 
had good total QOL score. This might happen because they 
were not ready to accept that they suffer from this disorder 
due to social stigma. Similar results were noted in the 
studies conducted by Mishal Alosaimi A et al (12) who noted 
that the patients who were not compliant to treatment had 
low QOL. 
Increased seizure frequency had major effect on the patients 
QOL as concluded from many studies. Gebre AH et al (10) 
reported seizure frequency to be significant predictor of 
QOL. A study conducted by Prem Singh et al (15) concluded 
that the QOL falls with increased seizure frequency; similar 
results were reported from this study. The patients who 
experienced seizures weekly had low QOL as compare to the 
patients who had not experienced seizure from past one 
year. Brusturen-Bota E et al (13), Thomas SV et al (17) and 
Mrabet H et al (25) also reported same findings. 
CONCLUSION 
It is evident from the study that the patients with epilepsy 
have low quality of life. Quality of life of patients with 
epilepsy falls with unemployment, with the use of 
combination therapy. Socio-demographic characters like 
lower class people had low QOL score. Although, there was 
no significant differences in the mean of total QOL between 
groups for socio-demographic and clinical characteristics. 
The total QOILE-31 score was low 39.12. 
Counseling and addressing other aspects of health well-
being is likely to achieve better health outcomes and 
enhancing awareness in the society regarding the effective 
treatment options available through public educational 
campaigns may help in removing the stigma associated with 
epilepsy and improve the QOL of the patients. 
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